Mouse anti Human Cytochrome p450 26A1
X2049M
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetCYP26A1
Overview
- SupplierNordic-MUbio
- Product NameMouse anti Human Cytochrome p450 26A1
- Delivery Days Customer7
- Application Supplier NoteAntibody can be used for Western blotting (1-2 microg/ml) and immunohistochemistry on formalin-fixed, paraffin-embedded tissues (1-5 microg/ml). Optimal concentration should be evaluated by serial dilutions.
- ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry
- Applications SupplierWestern Blotting;ELISA;Western Blotting;Immunohistochemistry
- Category SupplierPrimary antibodies
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDF27 P6 A1
- ConjugateUnconjugated
- Gene ID1592
- Target nameCYP26A1
- Target descriptioncytochrome P450 family 26 subfamily A member 1
- Target synonymsCP26; CYP26; cytochrome P450 26A1; cytochrome P450 retinoic acid-inactivating 1; cytochrome P450, family 26, subfamily A, polypeptide 1; cytochrome P450, subfamily XXVIA, polypeptide 1; cytochrome P450RAI; hP450RAI; P450, retinoic acid-inactivating, 1; P450RAI; P450RAI1; retinoic acid 4-hydroxylase; retinoic acid-metabolizing cytochrome
- HostMouse
- IsotypeIgG2b
- Protein IDO43174
- Protein NameCytochrome P450 26A1
- Scientific DescriptionCYP450 26 (EC 1.14.-.-); Retinoic acid-metabolizing cytochrome; P450 retinoic acid-inactivating 1; P450RAI; hP450RAI; Retinoic acid 4-hydroxylase
- Shelf life instructionSee expiration date on vial
- ReactivityHuman
- Reactivity SupplierHuman
- Reactivity Supplier NoteHybridoma produced by the fusion of splenocytes from BALB/c mice immunized with a synthetic peptide derived from the C-terminus of the human CYP450 26A1 protein and mouse myeloma Ag8563 cells.
- UNSPSC12352203
References
- 1. Kumarakasingham, M., et al. (2005). Cytochrome p450 profile of colorectal cancer: Identification of markers of prognosis. Clin. Cancer Res. 11(10);3758-3765. 2. Sakai, Y., et al. (2004). CYP26A1 and CYP26C1 cooperate in degrading retinoic acid within the equatorial retina during later eye development. 276(1);143-157 3. Osanai, M. and Petkovich, M. (2005). Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. 67(5);1808-1817